Categories
Archives
- 2026
- 2025
- 2024
- 2023
Jun
17
UCB Announces Publication of Data in Brain Communications Demonstrating Positive Impact of KYGEVVI® (doxecitine and doxribtimine) in Patients with Thymidine Kinase 2 Deficiency (TK2d)
Jun
04
Supporting Families During Dravet Syndrome Awareness Month: A look into Camp Small Steps
Jun
03
Running Toward Relief: How Cassie is Reclaiming Her Life With Psoriatic Arthritis
May
14
UCB Issues Voluntary Recall of Select Lots of CIMZIA® Pre-Filled Syringes (PFS) in the United States
Apr
01
UCB’s Catherine Rives and Alexandria Harrold Recognized by Healthcare Businesswomen’s Association (HBA) as Luminary and Rising Star
Mar
27
Evolving Expectations in Immunologic Disease: Our work with those living with immune-mediated diseases and HCPs
Mar
16
3 in 3: Advancing hope for rare and ultra-rare disease communities, one innovation at a time
Mar
10
Innovation Equals Access: How UCB Delivered for Patients in 2025
Feb
04
More than Medicine: UCB's Holistic Approach to Supporting MG Patients
